zinc
may
new
risk
factor
pneumonia
elderli
special
articl
review
magnitud
problem
pneumonia
preval
morbid
mortal
elderli
etiolog
dysregul
immun
system
associ
increas
age
addit
present
evid
literatur
includ
work
recent
low
zinc
statu
commonli
report
elderli
impair
immun
function
decreas
resist
pathogen
associ
increas
incid
durat
pneumonia
increas
use
durat
antimicrobi
treatment
also
increas
overal
mortal
elderli
inadequ
store
zinc
might
therefor
risk
factor
pneumonia
elderli
random
doubl
blind
control
studi
need
determin
efficaci
zinc
supplement
potenti
low
cost
intervent
reduc
morbid
mortal
due
pneumonia
vulner
popul
pleas
provid
three
five
key
word
phrase
zinc
new
risk
factor
pneumonia
elderli
special
articl
review
magnitud
problem
pneumonia
elderli
preval
morbid
mortal
especi
nurs
home
elderli
etiolog
pneumonia
dysregul
immun
system
associ
age
implic
pneumonia
elderli
addit
discuss
role
zinc
immun
respons
impact
low
zinc
statu
increas
morbid
mortal
due
pneumonia
also
allcaus
mortal
elderli
pneumonia
major
public
health
problem
elderli
gener
nurs
home
nh
resid
particular
elderli
higher
morbid
mortal
pneumonia
one
top
lead
caus
death
unit
state
older
adult
recoveri
pneumonia
elderli
take
longer
complic
mortal
also
frequent
younger
adult
pneumonia
one
common
caus
hospit
decreas
activ
daili
live
adl
among
elderli
recent
data
indic
incid
mortal
pneumonia
rise
elderli
cost
associ
hospit
due
commun
acquir
pneumonia
cap
includ
nh
resid
report
billion
cost
significantli
greater
admit
nh
infect
major
reason
transfer
nh
resid
acut
care
hospit
pneumonia
lead
caus
infect
requir
hospit
pneumoniarel
hospit
rate
nh
resid
nearli
time
higher
independ
live
elderli
nine
patient
acquir
pneumonia
nh
transfer
hospit
death
rate
pneumonia
nh
elderli
may
reach
high
kaplan
et
al
report
death
pneumonia
elderli
admit
hospit
twice
admiss
due
caus
year
hospit
differ
death
rate
pneumonia
caus
could
attribut
differ
underli
diseas
cost
treatment
nh
pneumonia
case
hospit
cost
exce
given
current
million
nurs
home
resid
usa
averag
pneumonia
incid
rate
per
person
per
year
translat
million
dollar
year
cost
associ
pneumonia
therapi
wide
rang
differ
bacteri
viral
pathogen
respons
cap
elderli
well
nhacquir
pneumonia
nhp
us
foremost
among
streptococcu
pneumonia
account
half
case
commonli
encount
bacteri
pathogen
includ
staphylococcu
aureu
haemophilu
influenza
chlamydia
pneumonia
moraxella
catarrhali
legionella
pneumophila
mycoplasma
pneumonia
gramneg
rod
klebsiella
pneumonia
e
coli
recent
year
role
viral
pathogen
etiolog
acut
lower
respiratori
tract
infect
alri
institution
noninstitution
elderli
increasingli
describ
influenza
well
recogn
caus
viral
pneumonia
age
sever
studi
recent
year
demonstr
import
parainfluenza
viru
piv
respiratori
syncyti
viru
rsv
adenoviru
human
metapneumoviru
hmpv
marri
colleagu
attribut
viral
caus
patient
nhp
etiolog
agent
includ
influenza
b
cytomegaloviru
piv
piv
hmpv
coronaviru
also
report
longterm
care
facil
boston
period
mani
factor
presenc
certain
comorbid
medic
condit
eg
chronic
obstruct
pulmonari
diseas
use
certain
drug
chang
physiochem
characterist
nonspecif
host
defens
system
cilia
mucu
respiratori
tract
malnutrit
mechan
devic
contribut
increas
incid
pneumonia
among
elderli
howev
import
predispos
factor
increas
incid
infect
welldescrib
ageassoci
declin
immun
respons
chang
immun
respons
decreas
resist
pathogen
also
contribut
increas
morbid
mortal
due
infect
adequ
function
immun
system
becom
critic
determin
outcom
infect
among
elderli
alreadi
compromis
presenc
diseas
physiolog
chang
consider
evid
indic
age
associ
impair
regul
immun
system
declin
immun
function
contribut
increas
incid
infecti
inflammatori
neoplast
diseas
observ
elderli
subject
well
prolong
postil
recoveri
period
prospect
studi
indic
higher
incid
morbid
mortal
elderli
subject
low
delayedtyp
hypersensit
dth
respons
vivo
measur
cellmedi
immun
respons
differ
cell
immun
system
contribut
impair
immun
old
age
cell
shown
major
contributor
vivo
cell
depend
function
dth
resist
viral
bacteri
challeng
respons
cell
depend
vaccin
depress
age
vitro
prolif
respons
lymphocyt
phytohemagglutinin
pha
concanavalin
con
cell
receptor
becom
depress
age
antigen
mitogen
stimul
accumul
declin
age
contribut
cell
mediat
defect
observ
age
alter
cell
function
attribut
intrins
chang
cell
includ
shift
distribut
function
distinct
cell
subset
increas
accumul
memori
cell
decreas
cell
diminish
abil
cell
produc
progress
cell
cycl
divis
chang
effici
earli
signal
transduct
event
abil
cell
produc
respond
cell
growth
factor
express
receptor
well
increas
prostaglandin
product
report
ageassoci
chang
product
cytokin
less
consist
exampl
decreas
increas
chang
product
tumor
necrosi
note
looney
et
al
show
peripher
blood
mononuclear
cell
pbmc
old
subject
produc
significantli
less
compar
young
subject
stimul
autolog
dendrit
cell
dc
infect
rsv
suggest
age
may
associ
defect
cell
respons
rsv
humor
respons
rsv
test
differ
adult
age
group
shown
older
frail
elderli
adult
lower
neutral
antibodi
titr
young
adult
neutral
antibodi
titr
declin
age
find
provid
potenti
mechan
increas
morbid
observ
rsv
infect
elderli
abil
antigen
present
cell
macrophag
dc
process
present
antigen
cell
part
maintain
older
individu
innat
immun
consist
phagocyt
cell
natur
killer
nk
cell
continu
function
reason
well
studi
indic
chemotaxi
adher
phagocyt
abil
monocyt
polymorphonuclear
cell
pmn
affect
age
although
decreas
respiratori
burst
monocyt
pmn
product
reactiv
oxygen
speci
chemotaxi
elderli
compar
young
subject
report
zinc
addit
cofactor
enzym
essenti
membran
integr
dna
synthesi
cell
prolifer
thu
need
highli
prolifer
cell
especi
immun
cell
zinc
shown
play
import
role
regul
immun
respons
particularli
cellmedi
function
similar
chang
observ
elderli
immun
respons
zinc
defici
associ
thymu
involut
reduct
lymphocyt
prolifer
dth
antibodi
respons
vaccin
memori
cell
ratio
indic
lower
product
report
effect
zinc
cell
innat
immun
system
less
consist
decreas
increas
chang
pmn
function
report
due
chang
zinc
statu
like
elderli
zinc
defici
subject
greater
suscept
varieti
pathogen
sever
investig
report
low
zinc
statu
decreas
intak
elderli
subject
furthermor
low
zinc
statu
elderli
contribut
ageassoci
dysregul
immun
respons
zinc
supplement
shown
improv
cell
function
elderli
thu
zinc
defici
indic
risk
factor
immun
defici
suscept
infect
elderli
zinc
supplement
may
therefor
play
import
role
prevent
infecti
diseas
elderli
variou
studi
zinc
supplement
elderli
observ
increas
circul
zinc
concentr
well
enhanc
immun
statu
includ
improv
cellmedi
immun
respons
product
increas
respons
dth
random
doubleblind
placebocontrol
clinic
trial
institution
elderli
year
signific
decreas
mean
number
respiratori
infect
supplement
period
micronutri
contain
mg
zinc
selenium
zinc
sulfat
selenium
sulfid
respect
vitamin
anoth
larger
random
doubleblind
placebocontrol
intervent
studi
lowdos
zinc
selenium
supplement
zinc
sulfat
selenium
sulfid
respect
significantli
increas
humor
respons
institution
elderli
age
year
vaccin
number
without
respiratori
infect
studi
also
found
higher
elderli
receiv
trace
element
period
studi
suggest
protect
effect
zinc
respiratori
tract
infect
contribut
nutrient
present
mixtur
rule
recent
studi
prasad
et
al
show
supplement
mgday
element
zinc
glucon
form
month
small
number
elderli
age
year
significantli
reduc
incid
infect
includ
respiratori
infect
effect
pneumonia
could
evalu
due
low
rate
event
author
conclud
result
encourag
need
repeat
larger
number
particip
decreas
infect
zinc
supplement
suggest
due
improv
cell
mediat
function
shown
increas
mrna
level
addit
studi
zinc
supplement
associ
decreas
product
proinflammatori
cytokin
dna
lipid
oxid
recent
show
observ
studi
nh
resid
year
low
serum
zinc
level
despit
supplement
mgday
zinc
sulfat
form
period
one
year
allcaus
mortal
lower
rr
normal
versu
low
preintervent
baselin
serum
zinc
concentr
tabl
control
comorbid
risk
factor
pneumonia
variabl
found
significantli
differ
low
normal
baselin
serum
zinc
concentr
model
materi
chang
statist
signific
differ
observ
find
suggest
zinc
may
play
crucial
role
influenc
allcaus
mortal
elderli
similarli
risk
mortal
reduc
particip
agerel
eyediseas
studi
are
age
year
receiv
high
dose
zinc
mgday
zinc
oxid
median
followup
year
rr
ci
howev
author
also
note
increas
hospit
admiss
among
receiv
high
dose
zinc
due
genitourinari
complic
observ
studi
subject
normal
postintervent
final
serum
zinc
concentr
lower
pneumonia
incid
reduc
total
antibiot
use
almost
shorter
durat
pneumonia
antibiot
use
day
respect
pvalu
rel
low
final
zinc
concentr
tabl
control
known
pneumonia
risk
factor
variabl
found
significantli
differ
low
normal
final
serum
zinc
concentr
age
percent
lymphocyt
serum
albumin
concentr
coronari
arteri
diseas
statin
use
multipl
regress
analys
model
materi
chang
statist
signific
differ
observ
studi
abl
show
signific
differ
suscept
pneumonia
use
preintervent
baselin
serum
zinc
concentr
measur
zinc
statu
like
higher
risk
death
among
subject
low
baselin
zinc
concentr
due
loss
subject
seriou
ill
andor
hospit
may
attenu
find
addit
baselin
zinc
concentr
may
reflect
zinc
statu
much
studi
period
studi
particip
ie
treatment
iuday
vitamin
e
placebo
iuday
vitamin
e
group
provid
rda
supplement
includ
mention
zinc
zinc
sulfat
effect
observ
specif
zinc
micronutri
addit
lower
incid
morbid
pneumonia
observ
subject
normal
final
zinc
concentr
compar
low
final
zinc
concentr
due
differ
two
group
chang
weight
bmi
micronutri
studi
period
low
final
serum
zinc
level
also
due
higher
incid
pneumonia
last
month
studi
higher
creactiv
protein
crp
lower
albumin
level
studi
role
supplement
zinc
immun
paramet
infect
elderli
micronutri
given
addit
zinc
improv
immun
respons
infect
studi
attribut
zinc
alon
number
studi
done
children
elderli
clearli
demonstr
benefici
impact
supplement
zinc
alon
immun
function
prevent
infect
found
sever
virus
detect
nh
resid
boston
area
virus
detect
significantli
higher
frequenc
alri
includ
pneumonia
data
indic
multipl
viral
pathogen
circul
nh
like
associ
clinic
signific
ill
furthermor
significantli
rsv
infect
vs
note
low
zinc
level
falsey
et
al
unpublish
data
similar
trend
note
piv
infect
although
reach
statist
signific
result
observ
studi
addit
find
studi
describ
suggest
inadequ
store
zinc
might
risk
factor
pneumonia
elderli
elderli
low
serum
zinc
concentr
might
therefor
benefit
zinc
supplement
measur
potenti
reduc
number
durat
pneumonia
episod
total
amount
durat
antibiot
use
due
pneumonia
also
allcaus
mortal
elderli
base
care
review
literatur
given
upper
safe
limit
zinc
dose
mg
element
zinc
per
day
might
adequ
improv
immun
function
reduc
risk
infect
howev
need
emphas
order
provid
conclus
evid
support
recommend
substanti
find
describ
random
doubl
blind
control
studi
adequ
number
particip
need
determin
efficaci
zinc
supplement
potenti
low
cost
intervent
reduc
morbid
mortal
due
pneumonia
vulner
popul
result
studi
potenti
significantli
improv
health
span
qualiti
life
elderli
result
substanti
save
order
million
dollar
might
save
cost
associ
health
care
elderli
particular
elderli
resid
nh
crude
valu
overal
death
data
analyz
use
baselin
serum
zinc
level
serum
zinc
group
serum
zinc
group
analyz
use
final
serum
zinc
level
poisson
regress
analys
use
incid
pneumonia
number
antibiot
prescript
least
squar
regress
analys
durat
pneumonia
antibiot
use
analys
control
treatment
supplement
iuday
vitamin
e
placebo
period
one
year
vitamin
e
placebo
group
also
receiv
capsul
contain
recommend
dietari
allow
rda
essenti
micronutri
includ
mgday
zinc
sulfat
form
age
sex
chronic
obstruct
lung
diseas
current
smoke
diabet
mellitu
year
enrol
baselin
chang
bmi
baselin
followup
addit
control
coronari
arteri
diseas
separ
model
baselin
serum
albumin
chang
serum
albumin
concentr
baselin
followup
affect
observ
associ
p
valu
deriv
poisson
least
squar
regress
analys
cox
proport
hazard
regress
analysi
use
mortal
data
analys
control
treatment
see
age
sex
chronic
obstruct
lung
diseas
current
smoke
diabet
mellitu
year
enrol
baselin
bmi
addit
control
coronari
arteri
diseas
separ
model
baselin
serum
albumin
concentr
affect
observ
associ
p
valu
deriv
cox
proport
hazard
regress
analysi
